Imaginostics, Inc.

Imaginostics creates innovative, non-invasive diagnostic solutions using breakthrough quantitative imaging biomarkers to provide new insight in health and disease. They are advancing patient care through their safe, noninvasive quantitative imaging technology which is compatible with existing MRI scanners and hardware. Data can be used to visualize the vasculature, assay health and disease, stratify patient populations, provide early preventative diagnostics, and assess drug efficacy in clinical trials.